Seeking Alpha·2d ago
DocGo Inc. (DCGO) Discusses Pending Acquisition of Hicuity Health and Related Financial Projections TranscriptDocGo Inc. (DCGO) Discusses Pending Acquisition of Hicuity Health and Related Financial Projections Transcript
DocGo faces a challenging fundamental outlook as its reliance on volatile, project-based municipal contracts leads to significant revenue contraction and persistent operating losses. The company's inability to maintain positive operating margins, which deterio...
Price trend, volume and key moving averages
Trailing total returns as of 10/2/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 17, 2026 | -$0.16-64.1% vs -$0.10 | $73M-2.6% vs $75M |
Q2 2026 May 11, 2026 | -$0.12-500.0% vs -$0.02 | $76M+4.2% vs $72M |
Q2 2026 Mar 16, 2026 | -$1.37-1270.0% vs -$0.10 | $75M+6.6% vs $70M |
Q4 2025 Nov 10, 2025 | -$0.28-211.1% vs -$0.09 | $71M+1.5% vs $70M |
DocGo Inc. (DCGO) Discusses Pending Acquisition of Hicuity Health and Related Financial Projections Transcript
Shares of DocGo Inc. (NASDAQ: DCGO - Get Free Report) have received a consensus recommendation of "Hold" from the six brokerages that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the company. The
DocGo Inc. (Nasdaq: DCGO) (âDocGoâ), a leading provider of technology-enabled mobile health and medical transportation services, announced today that Lee Bi
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health and medical transportation services, announced today that Lee Bienstock, Chief Executive Officer, and senior Hicuity Health executives will conduct a webinar on Tuesday September 29th at 11:00 a.m. ET to discuss DocGo's pending acquisition of Hicuity Health – a leading provider of tele-ICU, virtual nursing, telemetry monitoring and additional virtual care services to hospitals.
Benchmark DCGO against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for DocGo Inc. (DCGO)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.39 | $38.94M | -0.21 | -47.74% | -56.61% | -82.71% | — | |
| $8.39 | $157.44M | 31.07 | 18.78% | 4.66% | 3.6% | — | |
| $5.25 | $879.44M | 131.25 | 22% | 0.08% | 0.17% | — | |
| $29.30 | $6.54B | 57.45 | 59% | -5.51% | -30.03% | — | |
| $28.50 | $5.33B | 29.08 | 13.05% | 25.48% | 16.95% | — | |
| $170.29 | $2.17B | -35.85 | -27.99% | -2.23% | -2.99% | — |
DocGo Inc. (DCGO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
DocGo Inc. (DCGO) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 17, 2026·SEC
Jul 31, 2026·SEC
Jul 2, 2026·SEC
Get notified when DCGO posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
DocGo Inc. (DCGO) stock FAQ — growth, dividends, profitability & financials explained
DocGo Inc. (DCGO) reported $294.7M in revenue for fiscal year 2025. This represents a 510% increase from $48.3M in 2019.
DocGo Inc. (DCGO) saw revenue decline by 47.7% over the past year.
DocGo Inc. (DCGO) reported a net loss of $192.4M for fiscal year 2025.
DocGo Inc. (DCGO) has a return on equity (ROE) of -82.7%. Negative ROE indicates the company is unprofitable.
DocGo Inc. (DCGO) had negative free cash flow of $27.1M in fiscal year 2025, likely due to heavy capital investments.
